Latest News
Castle Biosciences, Inc.
- How Investors Are Reacting To Castle Biosciences (CSTL) TissueCypher Study Data
- Castle Biosciences CEO Derek Maetzold sells $462,567 in stock
- Form 4 Castle Biosciences Inc: Derek J. Maetzold (Director, Pres. & Chief Exec. Officer) For: 19 October
- Form 144 CASTLE BIOSCIENCES INC For: 18 October By Investing.com
- Form 144 Castle Biosciences For: 17 October By Investing.com
- Castle Biosciences CCO Tobin sells $110,608 in stock By Investing.com
- Castle Biosciences (CSTL) Chief Commercial Officer Tobin Juvenal Sells 3,288 Shares
- Castle Biosciences presents Barrett’s esophagus test data at ACG
- Castle Biosciences president and CEO Derek Maetzold sells $515k stock
- An officer and two trusts propose selling 28,992 shares of Castle Biosciences (CSTL).
- Form 4 Castle Biosciences Inc For: 26 September By Investing.com
- Castle Biosciences CEO sells $512k in stock
Headlines from the last 30 days, linking to the original publishers. See all market news →